Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein

Molecular Cell

Volumn 8, Issue 5, 2001, Pages 995-1004

  Peschard, Pascal ^a   Fournier, Tanya M ^a   Lamorte, Louie ^a   Naujokas, Monica A ^a   Band, Hamid ^b   Langdon, Wallace Y ^c   Park, Morag ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CBL PROTEIN; MUTANT PROTEIN; ONCOPROTEIN; PHENYLALANINE; POLYUBIQUITIN; PROTEIN TYROSINE KINASE; TRANSFORMING PROTEIN; TYROSINE; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN;

ARTICLE; BINDING SITE; CONTROLLED STUDY; EPITHELIUM CELL; FIBROBLAST; GENE MUTATION; HUMAN; HUMAN CELL; PROTEIN BINDING; PROTO ONCOGENE;

EID: 0035930341     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(01)00378-1     Document Type: Article

References (45)

1. Phosphotyrosine binding domain-dependent upregulation of the platelet-derived growth factor receptor alpha signaling cascade by transforming mutants of Cbl: Implications for Cbl's function and oncogenicity
2. Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25)
3. Efficient cellular transformation by the Met oncoprotein requires a functional Grb2 binding site and correlates with phosphorylation of the Grb2-associated proteins, Cbl and Gab1
4. Branching tubulogenesis but not scatter of madin-darby canine kidney cells requires a functional Grb2 binding site in the Met receptor tyrosine kinase
5. Cbl-transforming variants trigger a cascade of molecular alterations that lead to epithelial mesenchymal conversion
6. Tyrosine phosphorylation of Cbl upon epidermal growth factor (EGF) stimulation and its association with EGF receptor and downstream signaling proteins
7. Phosphorylation of serine 985 negatively regulates the hepatocyte growth factor receptor kinase
8. The proto-oncogene c-Cbl is a positive regulator of Met-induced MAP kinase activation: A role for the adaptor protein Crk
9. D-Cbl, the Drosophila homologue of the c-Cbl proto-oncogene, interacts with the Drosophila EGF receptor in vivo, despite lacking C-terminal adaptor binding sites
10. The protooncogene c-sea encodes a transmembrane protein-tyrosine kinase related to the Met/hepatocyte growth factor/scatter factor receptor
11. Hepatocyte growth factor/scatter factor-Met signaling in tumorigenicity and invasion/metastasis
12. Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway
13. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase
14. Coendocytosis of cadherin and c-Met coupled to disruption of cell-cell adhesion in MDCK cells - Regulation by Rho, Rac and Rab small G proteins
15. Mutational analysis of the role of the carboxy-terminal region of the v-erbB protein in erythroid cell transformation
16. The Cbl protooncoprotein stimulates CSF-1 receptor multiubiquitination and endocytosis, and attenuates macrophage proliferation
17. c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor
18. Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1
19. The evolutionarily conserved N-terminal region of Cbl is sufficient to enhance down-regulation of the epidermal growth factor receptor
20. A novel phosphotyrosine-binding domain in the N-terminal transforming region of Cbl interacts directly and selectively with ZAP-70 in T cells
21. The Cbl phosphotyrosine-binding domain selects a D(N/D)XpY motif and binds to the Tyr292 negative regulatory phosphorylation site of ZAP-70
22. Coupling of the proto-oncogene product c-Cbl to the epidermal growth factor receptor
23. Interactions of Drosophila Cbl with epidermal growth factor receptors and role of Cbl in R7 photoreceptor cell development
24. Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase
25. The tyrosine kinase regulator Cbl enhances the ubiquitination and degradation of the platelet-derived growth factor receptor alpha
26. Cbl-mediated negative regulation of platelet-derived growth factor receptor-dependent cell proliferation. A critical role for Cbl tyrosine kinase-binding domain
27. Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors
28. Dimerization mediated through a leucine zipper activates the oncogenic potential of the met receptor tyrosine kinase
29. Oncogenic activation of tyrosine kinases
30. Alternative splicing generates isoforms of the met receptor tyrosine kinase which undergo differential processing
31. Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor
32. InIB-dependent internalization of Listeria is mediated by the met receptor tyrosine kinase
33. The v-sea oncogene of avian erythroblastosis retrovirus S13: Another member of the protein-tyrosine kinase gene family
34. EGF receptor binding and transformation by v-cbl is ablated by the introduction of a loss-of-function mutation from the Caenorhabditis elegans sli-1 gene
35. Cbl: Many adaptations to regulate protein tyrosine kinases
36. RING finger mutations that abolish c-Cbl-directed polyubiquitination and downregulation of the EGF receptor are insufficient for cell transformation
37. Loss of the exon encoding the juxtamembrane domain is essential for the oncogenic activation of TPR-MET
38. Protein tyrosine phosphatase PTP-S binds to the juxtamembrane region of the hepatocyte growth factor receptor Met
39. The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells
40. The RING finger of c-Cbl mediates desensitization of the epidermal growth factor receptor
41. Mutation of juxtamembrane tyrosine residue 1001 suppresses loss-of-function mutations of the met receptor in epithelial cells
42. Ligand-induced ubiquitination of the epidermal growth factor receptor involves the interaction of the c-Cbl RING finger and UbcH7
43. Similarity of sli-1, a regulator of vulval development in C. elegans, to the mammalian proto-oncogene c-cbl
44. Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases
45. Tyrosine 1356 in the carboxyl-terminal tail of the HGF/SF receptor is essential for the transduction of signals for cell motility and morphogenesis